Table 1.
Correlation of HIF-1α, CXCR4, and VEGF expression with clinicopathologic features in colon cancer. Sections were subjected to routine deparaffinization and rehydration. Antigen retrieval was achieved by microwaving in citrate buffer for 10 min. The endogenous peroxidase activity was inhibited by incubation with 3% hydrogen peroxide. The specimens were reacted overnight with anti-HIF-1α antibodies, anti-CXCR4 antibodies, and anti-VEGF antibodies, then were incubated with rat anti-mouse-IgG2b-horseradish peroxidase. The sections were then counterstained with hematoxylin and mounted (see Section 2). Staining intensity and percentage of positive tumor cells were assessed. Multiplication of the intensity and the percentage scores gave rise to the final staining score: 0 (negative), + (1–4), ++ (5–8), and +++ (9–12). For statistical analysis, tumors having staining scores of 0 or + were designated the low expression group, and tumors with scores of ++ or +++ the high expression group. The correlation between clinicopathologic parameters and HIF-1α, CXCR4, and VEGF expression were analyzed by Chi-squared test or Fisher's exact test. Abbreviations: HIF-1α: Hypoxia-inducible factor-1; CXCR4: CXC chemokine receptor 4; VEGF: vascular endothelial growth factor; HPP: hyperplastic polyps; TNM: tumor-node-metastasis.
| Clinicopathologic parameters | Case No. | HIF-1α expression | P value | CXCR4 expression | P value | VEGF expression | P value | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Low | High | Low | High | Low | High | |||||
| Total cases | 68 | 38 | 30 | 27 | 41 | 24 | 44 | |||
| Age | ||||||||||
| ≤60 | 19 | 12 | 10 | P = .878 | 8 | 11 | P = .801 | 9 | 10 | P = .195 |
| >60 | 49 | 26 | 20 | 19 | 30 | 15 | 34 | |||
| Tissue type | ||||||||||
| Normal colonic tissue | 10 | 10 | 0 | P = .002a | 10 | 0 | P < .001a | 10 | 0 | P < .001a |
| HPP | 8 | 8 | 0 | P = .006b | 8 | 0 | P < .001b | 8 | 0 | P < .001b |
| Colon cancer | 68 | 38 | 30 | P = .019c | 27 | 41 | P = .001c | 24 | 44 | P = .001c |
| Sex | ||||||||||
| Male | 41 | 24 | 17 | P = .587 | 15 | 26 | P = .639 | 14 | 27 | P = .807 |
| Female | 27 | 14 | 13 | 11 | 15 | 10 | 17 | |||
| Tumor size | ||||||||||
| ≤5 cm | 27 | 16 | 11 | P = .649 | 13 | 14 | P = .297 | 17 | 10 | P = .340 |
| >5 cm | 41 | 32 | 19 | 25 | 16 | 21 | 20 | |||
| TNM stage | ||||||||||
| I | 6 | 5 | 1 | 5 | 1 | 4 | 2 | |||
| II | 30 | 23 | 7 | P = .001 | 16 | 14 | P = .003 | 15 | 15 | P = .008 |
| III | 25 | 9 | 16 | 6 | 19 | 5 | 20 | |||
| IV | 7 | 1 | 6 | 0 | 7 | 0 | 7 | |||
| Lymph node metastasis | ||||||||||
| Negative | 36 | 28 | 8 | P < .001 | 21 | 16 | P = .001 | 19 | 17 | P = .001 |
| Positive | 32 | 10 | 22 | 6 | 26 | 5 | 27 | |||
| Distant metastasis | ||||||||||
| Negative | 61 | 37 | 24 | P = .019 | 27 | 34 | P = .037 | 24 | 37 | P = .046 |
| Positive | 7 | 1 | 6 | 0 | 7 | 0 | 7 | |||
aDenotes significant difference among the three tissue types.
bDenotes significant difference between colon cancer and normal colonic tissue.
cDenotes significant difference between colon cancer and HPP.